Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain Metastases

NCT06683703 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

118

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer Patients with Brain Metastases

Interventions

DRUG: Utidelone combined with Bevacizumab
DRUG: Utidelone
DRUG: Utidelone combined with Bevacizumab
DRUG: Utidelone combined with Bevacizumab

Sponsor

Beijing Biostar Pharmaceuticals Co., Ltd.